Breaking News

Vertellus Completes Upgrades for API Production

Expands market capabilities to include pharmaceutical use for Niacin

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Vertellus Specialties’ facility in Antwerp, Belgium has completed upgrades for the manufacture of Niacin (nicotinic acid) for pharmaceutical use. For 30 years the plant has produced Niacin USP and Niacinamide for human food applications and agricultural needs. Vertellus upgraded the facility to meet cGMP guidelines for the manufacture of an API and it has been inspected and approved by the U.S. FDA. Major changes include validation of all critical equipment, manufacturing processes, analytical m...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters